Literature DB >> 28608277

[Oral anticoagulation using coumarins - an update].

Christoph Sucker1, Jens Litmathe2.   

Abstract

Vitamin K antagonists (VKA) are used for the prophylaxis and treatment of thrombotic and thromboembolic events. Most important indications are venous thrombosis and pulmonary embolism, atrial fibrillation, and mechanical heart-valve replacement. Hence they are from high relevance for the neurologist and his daily praxis in cardio-neurological routine. Here, we give an overview about VKA with focus on mode of action, indications and efficacy, practical aspects of treatment, side effects, and monitoring.

Entities:  

Keywords:  Alternatives; Coumarins; Indications; Review; Self-management

Mesh:

Substances:

Year:  2017        PMID: 28608277     DOI: 10.1007/s10354-017-0577-z

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  58 in total

1.  Direct oral anticoagulants and the bleeding patient.

Authors:  Brendan Wood; Michelle Sholzberg; Alun Ackery
Journal:  CMAJ       Date:  2015-10-13       Impact factor: 8.262

Review 2.  [Update of guidelines for patient self-management of oral anticoagulation].

Authors:  S Braun; H Völler; C Soppa; U Taborski
Journal:  Dtsch Med Wochenschr       Date:  2009-03-13       Impact factor: 0.628

3.  Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.

Authors:  Jean-Yves Le Heuzey; Bettina Ammentorp; Harald Darius; Raffaele De Caterina; Richard John Schilling; Josef Schmitt; José Luis Zamorano; Paulus Kirchhof
Journal:  Thromb Haemost       Date:  2014-03-20       Impact factor: 5.249

4.  Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients.

Authors:  F Mentré; F Pousset; E Comets; B Plaud; B Diquet; G Montalescot; A Ankri; A Mallet; P Lechat
Journal:  Clin Pharmacol Ther       Date:  1998-01       Impact factor: 6.875

5.  Aspirin for preventing the recurrence of venous thromboembolism.

Authors:  Cecilia Becattini; Giancarlo Agnelli; Alessandro Schenone; Sabine Eichinger; Eugenio Bucherini; Mauro Silingardi; Marina Bianchi; Marco Moia; Walter Ageno; Maria Rita Vandelli; Elvira Grandone; Paolo Prandoni
Journal:  N Engl J Med       Date:  2012-05-24       Impact factor: 91.245

6.  Quality of anticoagulation management among patients with atrial fibrillation: results of a review of medical records from 2 communities.

Authors:  G P Samsa; D B Matchar; L B Goldstein; A J Bonito; L J Lux; D M Witter; J Bian
Journal:  Arch Intern Med       Date:  2000-04-10

Review 7.  Direct Oral Anticoagulants (DOACs): Current Status Among Distinct Patient Subgroups.

Authors:  Peter Riley; Abhishek Maan; Kenneth S Korr
Journal:  R I Med J (2013)       Date:  2017-05-01

Review 8.  Improvement of oral anticoagulation therapy by INR self-management.

Authors:  Dieter Horstkotte; Cornelia Piper
Journal:  J Heart Valve Dis       Date:  2004-05

Review 9.  [Breast feeding and oral anticoagulants].

Authors:  E Olthof; T W de Vries
Journal:  Tijdschr Kindergeneeskd       Date:  1993-10

Review 10.  New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs).

Authors:  Rick H van Gorp; Leon J Schurgers
Journal:  Nutrients       Date:  2015-11-17       Impact factor: 5.717

View more
  1 in total

Review 1.  [Oral anticoagulation : Current overview and perioperative management in ophthalmic surgery].

Authors:  C Sucker; A Hager; J Koscielny; N Feltgen
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.